Disturbance of plasma and platelet thrombospondin levels in sickle cell disease

American Journal of Hematology

Volumn 51, Issue 4, 1996, Pages 296-301

  Browne, Paul V ^b   Mosher, Deane F ^b   Steinberg, Martin H ^b   Hebbel, Robert P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Platelets; Sickle cell anemia; Thrombospondin

Indexed keywords

THROMBOSPONDIN;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THROMBOCYTE;

ACUTE DISEASE; ANEMIA, SICKLE CELL; BLOOD PLATELETS; HEMOGLOBIN SC DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; PAIN; PLATELET ACTIVATION; PLATELET ADHESIVENESS; SPLEEN; THROMBOSPONDINS;

EID: 0029979392     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R     Document Type: Article

References (30)

1. Hebbel RP: Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology. Blood 77:214, 1991.
2. Hebbel RP, Mohandas N: Sickle cell adherence. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds, "Sickle Cell Disease: Basic Principles and Clinical Practice." New York: Raven Press, pp 217, 1994.
3. Sugihara K, Sugihara T, Mohandas N, Hebbel RP: Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 80:2634, 1992.
4. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion. Blood 81:2137, 1993.
5. Lawler J, Hynes RO: Structural organization of the thrombospondin molecule. Semin Thromb Hemost 13:245, 1987.
6. Mosher DF: Physiology of thrombospondin. Annu Rev Med 41:85, 1990.
7. Frazier WA: Thrombospondins. Curr Opin Cell Biol 3:792, 1991.
8. Bornstein P: Thrombospondins: Structure and regulation of expression FASEB J 6:3290, 1992.
9. Lawler J, Duquette M, Whittaker CA, Adams JC, McHenry K, DeSimone DW: Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol 120:1059, 1993.
10. Dixit VM, Haverstick DM, O'Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA: A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci USA 82:3472, 1985.
11. Tuszynski GP, Kowalska MA: Thrombospondin-induced adhesion of human platelets. J Clin Invest 87:1387, 1991.
12. Long MW, Dixit VM: Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. Blood 75:2311, 1990.
13. Hogg PJ, Stenflo J, Mosher DF: Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry 31:265, 1992.
14. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497, 1993.
15. Harmon JT, Jamieson GA: Activation of platelets by α-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not Na-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor. J Biol Chem 261:15928, 1986.
16. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA: Studies of human platelet α-granule release in vivo. Blood 58:607, 1981.
17. Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeown-Longo PJ, Mosher DF: Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 80:998, 1983.
18. Allan D, Limbrick AR, Thomas P, Westerman MP: Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 295:612, 1982.
19. Wagner GM, Chiu D T-Y, Yee MC, Lubin B: Red cell vesiculation - a common membrane physiologic event. J Lab Clin Med 108:315, 1986.
20. Pearson HA, Gallagher D, Chilcote R, Sullivan E, Wilimas J, Espeland M, Ritchey AK, and the Cooperative Study of Sickle Cell Disease: Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 76:392, 1985.
21. Lane PA, O'Connell JL, Lear JL, Rogers ZR, Buchanan GR, Woods GM, Hassell KL, Wethers DL: Delayed development of functional asplenia in hemoglobin SC disease. Blood 82(suppl 1):355a, 1993.
22. Dawes J, Pratt DA, Dewar MS, Preston FE: Do extra-platelet sources contribute to the plasma level of thrombospondin? Thromb Haemost 59:273, 1988.
23. Francis RB Jr, Hebbel RP: Hemostasis. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press, pp 299-310, 1994.
24. Embury SH, Hebbel RP, Steinberg MH, Mohandas N: Pathogenesis of Vasoocclusion. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): "Sickle Cell Disease: Basic Principles and Clinical Practice." New York: Raven Press, pp 311-326, 1994.
25. Trzeciak M-C, McGregor J, Renaux J-L, Ville D, Berruyer M, Dawes J, Dechavanne M: Plasma thrombospondin in patients with chronic renal failure, liver disease and splenectomy. Thromb Res 40:121, 1985.
26. Hebbel RP, Steinberg MH, Mosher D: Plasma and platelet thrombospondin levels in sickle disease. Clin Res 41:726A, 1993.
27. Tomer A, Harker LA, Eckman JR: Activation of platelets and platelet and red cell procoagulant activity in sickle cell disease (abstract 196). National Sickle Cell Disease Program, Nineteenth Annual Meeting, March 23-26, 1994
28. Akinola NO, Stevens SME, Franklin IM, Nash GB, Stuart J: Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol 45:902, 1992.
29. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513, 1993.
30. Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS: Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol 81:539, 1992.